Strategic vs. Private Equity Buyers: Who Is the Right Partner for Your Pharma Services Company?
Companies across the clinical research ecosystem, including CROs, clinical research sites and site networks, site management organizations (SMOs), and patient recruitment and enrollment providers, continue to attract significant interest from both strategic acquirers and private equity investors. As clinical trial volume grows and the need for efficient patient access intensifies, well operated research organizations have […]
Valuation of Clinical Research Sites: What Buyers Look For in a Clinical Research Site Company
The clinical research site (CRS) sector has become one of the most active areas in life sciences M&A. With pharmaceutical companies accelerating development pipelines and competition for experienced trial sites intensifying, clinical research site businesses are increasingly viewed as strategic assets. For owners and operators, understanding the dynamics that influence valuation is essential to positioning […]